Pharma's Almanac TV
PA TV
Dashboard
Your Name
Your Email
Manage Account
Sign Out
Sign In
Register
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Research
CDMO
CRO
Excipients
Pharmaceutical Equipment
Pharmaceutical Intermediates
Supply Chain Logistics
Magazine
Current Issue
Archive
Community
Company A to Z
Content Filter
More+
Staffing
Media Kit
By The Numbers
GE Healthcare
17 Articles Available
Can't find what you're looking for? Try our
advanced search
.
Supply Chain
GE Healthcare Increases Production to Aid Coronavirus Patients
PR-M03-20-NI-033
China
GE Healthcare Life Sciences and Akeso Pharmaceuticals to Speed Up Novel Therapy Manufacturing in China
PR-M11-19-NI-015
Partnership
Volpara Solutions Expands Relationship with GE Healthcare
PR-M03-19-NI-083
Ethical Business Practices
Q: Given the ongoing evolution of the pharma industry today, how does your organization incorporate ethical concerns into your business practices?
PAP-Q1-2019-NI-001
Artificial Intelligence
Q: What do you believe the role of artificial intelligence and other advanced technologies will be in driving the development of the pharmaceutical industry over the next decade?
PAP-Q1-2019-NI-002
Immuno-oncology
GE Healthcare, Vanderbilt University Medical Center Partner for Safer, More Precise Immunotherapy Cancer Treatment
PR-M01-19-NI-023
Facility
GE Healthcare to Open Biotechnology Manufacturing Center in UK
PR-M11-18-NI-096
Artificial Intelligence
UK Hospital to Get Command Center Driven by AI and Real-Time Analytics
PAO-M10-18-NI-013
Cell and Gene Therapy
Cobra Biologics, GE Healthcare and Centre for Process Innovation Collaborate to Advance Gene Therapy
PR-M10-18-NI-002
Announcement
GE Healthcare to Become Standalone Company
PR-M06-18-NI-095
GE Healthcare Saves Providers Time and Money With More Workflows and New Analytics Solutions Powered by the Cloud
PR-M03-18-NI-029
Cell and Gene Therapy
Cell Therapy Companies Can Now Have Improved Cell Thawing Capabilities
PAO-M01-18-NI-042
Digital Platform
Clinical Decision-support Software to be Developed by Roche and GE Healthcare
PAO-M01-18-NI-028
Strategic Partnership
New Collaboration Targets the Development of Oligonucleotides
PAO-M12-17-NI-002
Innovation
Single-Use Operational Excellence Explained: Effective Lifecycle Management
PAP-Q4-17-CL-006
3D Printing
New 3D Printing Lab Dedicated to Pharma Opens in Sweden
PAO-M10-17-NI-020
Innovation
Women Gain New Control Over Mammogram Discomfort
PAO-M09-17-NI-016
